This brand name is authorized in Tunisia
The drug PARKIZOL contains one active pharmaceutical ingredient (API):
|
1
Trihexyphenidyl
UNII 6RC5V8B7PO - TRIHEXYPHENIDYL
|
|
Trihexyphenidyl is an anticholinergic agent. It is an antispasmodic drug which exerts a direct inhibitory effect on the parasympathetic nervous system. It diminishes salivation, increases the heart rate, dilates the pupils and reduces spasm of smooth muscle. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N04AA01 | Trihexyphenidyl | N Nervous system → N04 Anti-parkinson drugs → N04A Anticholinergic agents → N04AA Tertiary amines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6653212, 9073092 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
